BioCentury
ARTICLE | Clinical News

Single-agent ribavirin regulatory update

August 18, 2014 7:00 AM UTC

Pharmascience’s Pendopharm division said Health Canada approved single-agent Ibavyr ribavirin to treat HCV infection. Pendopharm said that ribavirin is available only in kits with interferon in Canada...